series-a
Stage
2023
Founded
1
Investors
About
Slate Medicines develops next-generation therapeutics for the prevention of migraine and other headache disorders, focusing on monoclonal antibodies targeting PACAP and VIP pathways.
Explore Slate Medicines Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.